Astra Zeneca Impact Challenge Grant – Cardiovascular/Diabetes

 

The Heart & Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE) and the Banting & Best Diabetes Centre (BBDC) in conjunction with the Vice-Dean, Research and Innovation, Faculty of Medicine, are pleased to announce the 2017 AstraZeneca Impact Challenge Grant in Cardiovascular/Diabetes Research competition.

One non-renewable award will be provided up to $250,000 ($125,000 annually for 2 years, to be spent over a maximum of 3 years). Funding for this competition will begin July 1, 2017.

The purpose of this funding program is to:

  • To foster bench to bedside translational research with a focus on innovation and first-in man clinical trials;
  • To foster the training of graduate students across disciplines and research institutes;
  • To establish the University of Toronto as an international leader in the study of diabetes and heart disease; and
  • To encourage collaboration between the BBDC and the HSRLCE.

Please see the Request for Applications for grant guidelines, eligibility criteria and more details.

Applications must be received by 4 pm on March 31, 2017.  Click here for the Application Form 

Questions regarding this program may be directed to the Business Manager, Heart & Stroke/Richard Lewar Centre of Excellence at hsrl.centre@utoronto.ca.

Documents:
Request for Applications – 2017 AstraZeneca Impact Challenge Grant
Application Form – 2017 AstraZeneca Impact Challenge Grant

wp_adminAstra Zeneca Impact Challenge Grant – Cardiovascular/Diabetes